{"id":"https://openalex.org/W4402014709","doi":"https://doi.org/10.1002/chir.23713","title":"Improved, Efficient, and Simple Methodology for the Resolution of Racemic Benoxaprofen: A Nonsteroidal Anti\u2010Inflammatory Drug (NSAID)","display_name":"Improved, Efficient, and Simple Methodology for the Resolution of Racemic Benoxaprofen: A Nonsteroidal Anti\u2010Inflammatory Drug (NSAID)","publication_year":2024,"publication_date":"2024-08-28","ids":{"openalex":"https://openalex.org/W4402014709","doi":"https://doi.org/10.1002/chir.23713","pmid":"https://pubmed.ncbi.nlm.nih.gov/39205493"},"language":"en","primary_location":{"id":"doi:10.1002/chir.23713","doi":"https://doi.org/10.1002/chir.23713","is_oa":false,"landing_page_url":"https://doi.org/10.1002/chir.23713","pdf_url":null,"source":{"id":"https://openalex.org/S67976470","display_name":"Chirality","issn_l":"0899-0042","issn":["0899-0042","1520-636X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031316807","display_name":"Siva Rama Kasibabu Velugula","orcid":"https://orcid.org/0000-0003-1407-2948","observed_orcids":["https://orcid.org/0000-0003-1407-2948"]},"institutions":[{"id":"https://openalex.org/I100887729","display_name":"Andhra University","ror":"https://ror.org/049skhf47","country_code":"IN","type":"education","lineage":["https://openalex.org/I100887729"]},{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Siva\u00a0Rama\u00a0Kasibabu Velugula","raw_affiliation_strings":["Chemical Research Department, APL Research Centre-II, Aurobindo Pharma Limited, Hyderabad, Telangana, India","Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam, Andhra Pradesh, India"],"raw_orcid":"https://orcid.org/0000-0003-1407-2948","affiliations":[{"raw_affiliation_string":"Chemical Research Department, APL Research Centre-II, Aurobindo Pharma Limited, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210110833"]},{"raw_affiliation_string":"Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam, Andhra Pradesh, India","institution_ids":["https://openalex.org/I100887729"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080681333","display_name":"Veera Babu Kagita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Veera\u00a0Babu Kagita","raw_affiliation_strings":["Chemical Research Department, APL Research Centre-II, Aurobindo Pharma Limited, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Research Department, APL Research Centre-II, Aurobindo Pharma Limited, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090441396","display_name":"Ramadas Chavakula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ramadas Chavakula","raw_affiliation_strings":["Chemical Research Department, APL Research Centre-II, Aurobindo Pharma Limited, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Research Department, APL Research Centre-II, Aurobindo Pharma Limited, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001221657","display_name":"Paul Douglas Sanasi","orcid":"https://orcid.org/0000-0002-5839-0959","observed_orcids":["https://orcid.org/0000-0002-5839-0959"]},"institutions":[{"id":"https://openalex.org/I100887729","display_name":"Andhra University","ror":"https://ror.org/049skhf47","country_code":"IN","type":"education","lineage":["https://openalex.org/I100887729"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Paul\u00a0Douglas Sanasi","raw_affiliation_strings":["Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam, Andhra Pradesh, India","institution_ids":["https://openalex.org/I100887729"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031316807"],"corresponding_institution_ids":["https://openalex.org/I100887729","https://openalex.org/I4210110833"],"apc_list":{"value":3840,"currency":"USD","value_usd":3840},"apc_paid":null,"fwci":0.5045,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.46925744,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"36","issue":"9","first_page":"e23713","last_page":"e23713"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.18029999732971191,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13115","display_name":"Axial and Atropisomeric Chirality Synthesis","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benoxaprofen","display_name":"benoxaprofen","score":0.9700000286102295},{"id":"https://openalex.org/keywords/racemic-resolution","display_name":"racemic resolution","score":0.7160000205039978},{"id":"https://openalex.org/keywords/enantiomeric-separation","display_name":"enantiomer separation","score":0.5960000157356262},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8650000095367432},{"id":"https://openalex.org/keywords/chiral-reagents","display_name":"chiral reagents","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9557654857635498},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.8087654113769531},{"id":"https://openalex.org/C2779703632","wikidata":"https://www.wikidata.org/wiki/Q581996","display_name":"Anti-inflammatory","level":2,"score":0.6525247097015381},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5560217499732971},{"id":"https://openalex.org/C138268822","wikidata":"https://www.wikidata.org/wiki/Q1051925","display_name":"Resolution (logic)","level":2,"score":0.5346875190734863},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5122029185295105},{"id":"https://openalex.org/C2780586882","wikidata":"https://www.wikidata.org/wiki/Q7520643","display_name":"Simple (philosophy)","level":2,"score":0.47906050086021423},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4617573916912079},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4249518811702728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/chir.23713","doi":"https://doi.org/10.1002/chir.23713","is_oa":false,"landing_page_url":"https://doi.org/10.1002/chir.23713","pdf_url":null,"source":{"id":"https://openalex.org/S67976470","display_name":"Chirality","issn_l":"0899-0042","issn":["0899-0042","1520-636X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"journal-article"},{"id":"pmid:39205493","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39205493","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W2011467023","https://openalex.org/W2016794021","https://openalex.org/W2021366114","https://openalex.org/W2036828292","https://openalex.org/W2045122308","https://openalex.org/W2050476404","https://openalex.org/W2086893455","https://openalex.org/W2337593314","https://openalex.org/W2772755903","https://openalex.org/W2952865782","https://openalex.org/W6902932655"],"related_works":["https://openalex.org/W2951114381","https://openalex.org/W2378373758","https://openalex.org/W2012234012","https://openalex.org/W2106847327","https://openalex.org/W2048921030","https://openalex.org/W2072389395","https://openalex.org/W2187933498","https://openalex.org/W2063668681","https://openalex.org/W2051772509","https://openalex.org/W2059234485"],"abstract_inverted_index":{"The":[0,23],"present":[1],"article":[2],"discloses":[3],"an":[4,29],"improved,":[5],"efficient,":[6,32],"and":[7,34],"simple":[8],"resolution":[9,24,42],"methodology":[10],"for":[11],"the":[12],"preparation":[13],"of":[14,25,50],"(S)-benoxaprofen":[15],"which":[16],"is":[17,44],"a":[18,46],"nonsteroidal":[19],"anti-inflammatory":[20],"drug":[21],"(NSAID).":[22],"racemic":[26],"benoxaprofen":[27],"uses":[28],"easily":[30],"available,":[31],"recoverable,":[33],"cost-effective":[35],"chiral":[36],"reagent,":[37],"namely,":[38],"(1R,2S)-(+)-cis-1-amino-2-indanol.":[39],"This":[40],"novel":[41],"process":[43],"having":[45],"very":[47],"high":[48],"purity":[49],"(S)-benoxaprofen,":[51],"greater":[52],"than":[53,60],"99%,":[54],"substantially":[55],"free":[56],"from":[57],"(R)-benoxaprofen":[58],"(less":[59],"1%).":[61]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-08-30T00:00:00"}